Proteolytic processing activates a viral superantigen

Journal of Experimental Medicine

Volumn 184, Issue 4, 1996, Pages 1549-1554

  Mix, Denise ^a   Winslow, Gary M ^a,b  

^a WADSWORTH CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FURIN; LEUPEPTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SUPERANTIGEN; VIRUS ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; HYBRIDOMA; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; CHO CELLS; CRICETINAE; FURIN; GENES, MHC CLASS II; LYMPHOCYTE ACTIVATION; MAMMARY TUMOR VIRUS, MOUSE; PROTEIN PROCESSING, POST-TRANSLATIONAL; SUBTILISINS; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 0029854620     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.4.1549     Document Type: Article

References (26)

1. Acha-Orbea, H., and H.R. MacDonald. 1995. Superantigens of mouse mammary tumor virus. Ann. Rev. Immunol. 13: 459-486.
2. a). Cell. 71:719-730.
3. Winslow, G.M., P. Marrack, and J.W. Kappler. 1994. Processing and Major Histocompatibility Complex binding of the MTV7 superantigen. Immunity. 1:23-34.
4. Barr, P.J. 1991. Mammalian subtilisins: the long-sought dibasic processing endoproteases. Cell. 66:1-3.
5. Steiner, D.F., S.P. Smeekens, S. Ohagi, and S.J. Chan. 1992. The new enzymology of precursor endoproteases. J. Biol. Chem. 267:23435-23438.
6. Nagai, Y. 1993. Protease-dependent virus tropism and pathogenicity. Trends Microbiol. 1:81-87.
7. McCune, J.M., L.B. Rabin, M.B. Feinberg, M. Lieberman, J.C. Kosek, G.R. Reyes, and I.L. Weissman. 1988. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell. 53:55-67.
8. Klenk, H.-D., and R. Rott. 1988. The molecular biology of influenza virus pathogenicity. Adv. Virus Res. 34:247-281.
9. Stieneke-Gröber, A., M. Vey, H. Angliker, E. Shaw, G. Thomas, C. Roberts, H.-D. Klenk, and W. Garten. 1992. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO (Eur. Mol. Biol. Organ.) J. 11:2407-2414.
10. Nagai, Y., H.-D. Klenk, and R. Rott. 1976. Proteolytic cleavage of the viral glycoprotein and its significance for the virulence of Newcastle disease virus. Virology. 72:494-508.
11. Brandt-Carlson, C., J.S. Butel, and D. Wheeler. 1993. Phylogenetic and structural analyses of MMTV LTR ORF sequences of exogenous and endogenous origins. Virology. 193: 171-185.
12. Winslow, G.M., J. Kappler, and P. Marrack. 1996. Structural Features of MMTV superantigens. In Superantigens: Structure, Biology, and Relevance to Human Disease. D. Leung, B. Huber, and P. Schlieverts. Marcel Dekker, New York. In press.
13. Park, C.G., M.-Y. Jung, Y. Choi, and G.M. Winslow. 1994. Proteolytic processing is required for viral superantigen activity. J. Exp. Med. 181:1899-1904.
14. Seidah, N.G., M. Chrétien, and R. Day. 1994. The family of subtilisin/kexin like pro-protein and pro-hormone convertases: divergent or shared functions. Biochimie. 76:197-209.
15. Gordon, V.M., K.R. Klimpel, N. Arora, M.A. Henderson, and S.H. Leppla. 1995. Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. Inf. Immunol. 63:82-87.
16. Miller, J., and R.N. Germain. 1986. Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain. J. Exp. Med. 164:1478-1489.
17. Wise, R.J., P.J. Barr, P.A. Wong, M.C. Kiefer, A.J. Brake, and R.J. Kaufman. 1990. Expression of a human proprotein processing enzyme: correct cleavage of the von Willebrand factor precursor at paired basic amino acid site. Proc. Natl. Acad. Sci. USA. 87:9378-9382.
18. Rehemtulla, A., and R.J. Kaufman. 1990. Preferred sequence requirements for cleavage of Pro-vonWillebrand factor by propeptide-processing enzymes. Blood. 79:2349-2355.
19. Ozato, K., N. Mayer, and D.H. Sachs. 1980. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J. Immunol. 124:533-540.
20. Mishell, R.I., and R.W. Dutton. 1967. Immunization of dissociated spleen cell cultures from normal mice. J. Exp. Med. 126:423-442.
21. White, J., A. Pullen, K. Choi, P. Marrack, and J.W. Kappler. 1993. Antigen recognition properties of mutant Vβ3+ T cell receptors are consistent with an immunoglobulin-like structure for the receptor. J. Exp. Med. 177:119-125.
22. White, J., M.A. Blackman, J. Bill, J. Kappler, P. Marrack, D.P. Gold, and W. Born. 1989. Two better cell lines for making hybridomas expressing specific T cell receptors. J. Immunol. 143:1822-1825.
23. Kappler, J.W., B. Skidmore, J. White, and P. Marrack. 1981. Antigen-inducible, H-2-restricted, interleukin-2 producing T cell hybridomas. Lack of independent antigen and H-2 recognition J. Exp. Med. 153:1198-1214.
24. Mukhopadhyay, R., D. Medina, and J.S. Butel. 1995. Expression of the mouse mammary tumor virus long terminal repeat open reading frame promotes tumorigenic potential of hyperplastic mouse mammary epithilial cells. Virology. 211: 84-93.
25. Seidah, N.G., J. Hamelin, M. Mamarbachi, W. Dong, H. Tadros, M. Mbikay, M. Chretien, and R. Day. 1996. cDNA structure, tissue distribution, and chromosomal localization of rat PC7, a novel mammalian proprotein convertase closest to yeast kexin-like proteinases. Proc. Natl. Acad. Sci. USA. 93: 3388-3393.
26. Wiley, D.C., and J.J. Skehel. 1987. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 56:365-394.